Marjaana Ojalill

6PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 06, 2026
C1s protects cutaneous squamous carcinoma cells from TRAIL-induced apoptosis.

Maria Salmela, Liisa Nissinen, Pekka Rappu

|Sep 26, 2025
Ovarian Tumor FAK Inhibition Releases Omega-3 Fatty Acids Stimulating GATA6 Peritoneal Macrophage CXCL13 Production Enhancing Immunotherapy.

Xiao Lei Chen, Kevin M Tharp, Marjaana Ojalill

|Nov 25, 2024
Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma.

Yichi Zhang, Marjaana Ojalill, Antonia Boyer

|Nov 22, 2024
Inducible FAK Deletion but not FAK Inhibition in Endothelial Cells Activates p53 to Suppress Tumor Growth in PYK2-null Mice.

Xiao Lei Chen, Marjaana Ojalill, Christine Jean

|Jul 22, 2024
Focal adhesion kinase signaling - tumor vulnerabilities and clinical opportunities.

David D Schlaepfer, Marjaana Ojalill, Dwayne G Stupack

|Apr 25, 2022
Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis.

Duygu Ozmadenci, Jayanth S Shankara Narayanan, Jacob Andrew

Pageof 1